Robert Martell - 29 Jan 2022 Form 4 Insider Report for CURIS INC (CRIS)

Role
Head of Research & Development
Signature
William Steinkrauss, attorney-in-fact
Issuer symbol
CRIS
Transactions as of
29 Jan 2022
Net transactions value
$0
Form type
4
Filing time
31 Jan 2022, 16:16:37 UTC
Next filing
24 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRIS Employee stock option (right to buy) Award $0 +252,000 $0.000000 252,000 29 Jan 2022 Common stock 252,000 $3.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option grant described in this Form 4 filing vests as to 25% of the original shares on January 29, 2023 and as to an additional 6.25% of the original shares each successive quarter and until January 29, 2026.